In rats subjected to MCAO, combination therapy using tPA and minocycline for 6 h was shown to reduce the amount of MMP-9 in plasma, decrease the volume of ischemic damage, and decrease intracranial hemorrhage compared to administration of tPA alone. The gene discussed is PLAT; the disease is intracranial hemorrhage.